Jeffrey P. Callen, M.D., FACP, FAAD

Jeffrey P. Callen, M.D., FACP, FAAD

Jeffrey P. Callen, M.D.

Jeffrey P. Callen, M.D., FACP, FAAD

  • Professor of Medicine
  • Chief, Division of Dermatology
3810 Springhurst Blvd.
Louisville, KY 40241

502-583-1749 - Patient Appointments / Academic Office

Clinical Expertise
Skin Signs of Systemic Diseases; Lupus Erythematosus; Dermatomyositis; Pyoderma Gangrenosum; Psoriasis; Systemic Therapies for Management of Skin Disease


Board Certifications

  • American Board of Internal Medicine -
    Internal Medicine
  • American Board of Dermatology

Education and Training

  • Medical School: University of Michigan
  • Residency: University of Michigan Affiliated Hospitals



Recent Publications

    • Robinson JK, Callen JP. Introducing the clinical evidence synopsis section. JAMA Dermatol. 2015 Feb 1;151(2):127. doi: 10.1001/jamadermatol.2014.1924. PubMed PMID: 25629937.
    • Robinson JK, Callen JP. Farewell to the evidence-based dermatology section. JAMA Dermatol. 2014 Nov;150(11):1220. doi: 10.1001/jamadermatol.2014.1923. PubMed PMID: 25188691.
    • Haeberle MT, Todd P, Callen JP, Bahrami S. Mycobacterium mucogenicum infection following dacryocystorhinostomy and Crawford tube placement. JAMA Dermatol. 2014 Sep;150(9):981-3. doi: 10.1001/jamadermatol.2014.251. PubMed PMID: 25054441.
    • Crittenden SC, Gilbert JE, Callen JP. Hydroxyurea-induced leg ulceration in a patient with a homozygous MTHFR polymorphism misdiagnosed as pyoderma gangrenosum. JAMA Dermatol. 2014 Jul;150(7):780-1. PubMed PMID: 24599173.
    • Robinson JK, Bhatia AC, Callen JP. Protection of patients' right to privacy in clinical photographs, video, and detailed case descriptions. JAMA Dermatol. 2014 Jan;150(1):14-6. doi: 10.1001/jamadermatol.2013.8605. PubMed PMID: 24305726.
    • Callen JP, Robinson JK. The importance of a name. JAMA Dermatol. 2013 Oct;149(10):1245. doi: 10.1001/jamadermatol.2013.5483. PubMed PMID: 24132323.
    • Callen JP. Drug-induced subacute cutaneous lupus erythematosus--filling the gap in knowledge: comment on "subacute cutaneous lupus erythematosus induced by chemotherapy". JAMA Dermatol. 2013 Sep;149(9):1075-6. doi: 10.1001/jamadermatol.2013.4958. PubMed PMID: 23842706.
    • Femia AN, Vleugels RA, Callen JP. Cutaneous dermatomyositis: an updated review of treatment options and internal associations. Am J Clin Dermatol. 2013 Aug;14(4):291-313. doi: 10.1007/s40257-013-0028-6. Review. PubMed PMID: 23754636.
    • Robinson JK, Callen JP. Introducing Misha Rosenbach, MD, section editor for JAMA Dermatology patient page. JAMA Dermatol. 2013 Mar;149(3):340. doi: 10.1001/jamadermatol.2013.2723. PubMed PMID: 23552528.
    • Wilkerson E, Hazey MA, Bahrami S, Callen JP. Golimumab-exacerbated subacute cutaneous lupus erythematosus. Arch Dermatol. 2012 Oct;148(10):1186-90. doi: 10.1001/archdermatol.2012.1856. PubMed PMID: 23069957.